Advertisement
Canada markets closed
  • S&P/TSX

    24,255.16
    +98.29 (+0.41%)
     
  • S&P 500

    5,728.80
    +23.35 (+0.41%)
     
  • DOW

    42,052.19
    +288.73 (+0.69%)
     
  • CAD/USD

    0.7168
    -0.0010 (-0.14%)
     
  • CRUDE OIL

    69.33
    +0.07 (+0.10%)
     
  • Bitcoin CAD

    95,473.45
    -1,839.20 (-1.89%)
     
  • XRP CAD

    0.70
    -0.01 (-2.07%)
     
  • GOLD FUTURES

    2,745.90
    -3.40 (-0.12%)
     
  • RUSSELL 2000

    2,210.13
    +13.48 (+0.61%)
     
  • 10-Yr Bond

    4.3610
    +0.0770 (+1.80%)
     
  • NASDAQ

    18,239.92
    +144.77 (+0.80%)
     
  • VOLATILITY

    21.88
    -1.28 (-5.53%)
     
  • FTSE

    8,177.15
    +67.05 (+0.83%)
     
  • NIKKEI 225

    38,053.67
    -1,027.53 (-2.63%)
     
  • CAD/EUR

    0.6612
    +0.0018 (+0.27%)
     

How Abbott Labs Is Leaning Into Obesity Treatment, And Taking On Dexcom

How Abbott Labs Is Leaning Into Obesity Treatment, And Taking On Dexcom

Abbott Laboratories launched its newest CGM in the U.S. on Thursday. The biosensor named Lingo is the first-ever for people without diabetes.